Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine

Clinical EEG Electroencephalography

Volumn 27, Issue 4 SUPPL., 1996, Pages 191-201

  Sangal, JoAnne M ^a,d   Sangal, R Bart ^a,b   Persky, Barry ^c  

^a Attention Disorders Institute

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WALDEN UNIVERSITY   (United States)

^d Attention Disorders Institute   (United States)

Author keywords

Attention Deficit Hyperactivity Disorder; Brain Topography; Imipramine, Treatment Response; P300

Indexed keywords

IMIPRAMINE; PEMOLINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MINIMAL BRAIN DYSFUNCTION; PRIORITY JOURNAL;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; IMIPRAMINE; MALE; PEMOLINE; REACTION TIME;

EID: 0029830367     PISSN: 00099155     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Quinn PO, Rapoport JL. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry 1975; 132: 241-245.
2. Gualtieri CT, Evans RW. Motor performance in hyperactive children treated with imipramine. Percept Mot Skills 1988; 66: 763-769.
3. McBride MC. An individual double-blind crossover trial for assessing methylphenidate responses in children with attention deficit disorder. J Pediatrics 1988; 113: 137-145.
4. Stevenson RD, Wolraich ML. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin North America 1989; 36: 1183-1197.
5. Stockard JJ, Iragui VJ. Clinically useful applications of evoked potentials in adult neurology. J Clin Neurophysiology 1984; 1: 159-202.
6. Klug N, Csecsei GS. Evoked potentials and brain stem reflexes. Neurosurg Rev 1985; 8: 63-84.
7. Picton TW. The P300 wave of the human event-related potential. J Clin Neurophysiology 1992; 9: 456-479.
8. Ruchkin DS, Sutton S. Equivocation and P300 amplitude. In: Otto D, (ed). Multidisciplinary Perspectives in Event-Related Potential Research. Washington, DC: U.S. Environmental Protection Agency; 1978: 175-177.
9. Goodin DS, Squires KC, Starr A. Long latency event-related components of the auditory evoked potential in dementia. Brain 1978; 101: 635-648.
10. Sangal JM, Sangal RB, Persky B. Abnormal auditory P300 topography in attention deficit disorder predicts poor response to pemoline. Clin Electroencephalogr 1995; 26: 204-213.
11. Diagnostic and Statistical Manual of Mental Disorders. (3rd ed. revised) Washington. DC: American Psychiatric Association; 1987.
12. Barkley RA. Behavior rating scales. In: Barkley RA (ed). Attention Deficit Hyperactivity Disorder: A handbook for diagnosis and treatment. New York: Guilford Press; 1990: 278-326.
13. Woodcock RA, Johnson MB. Woodcock-Johnson Psycho-Educational Battery - Revised. Tests of Cognitive Ability. Allen, TX: DLM Teaching Resources; 1990.
14. Sharbrough F, Chatrian G, Lesser RP, et al. Guidelines for Standard Electrode Position Nomenclature. Bloomfield, CT: American EEG Society; 1990.
15. Binnie CD, McGillivray BB. Brain mapping: useful tool or a dangerous toy? J Neurol Neurosurg Psychiatry 1993; 12: 527-529.
16. 2 methodology. Brain Topography 1990; 2: 237-245.
17. Abt K. Statistical aspects of neurophysiologic topography J Clin Neurophysiology 1990; 7: 519-534.
18. Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADD). Australian New Zealand J Psychiatry 1991; 25: 277-283.
19. Cooper JR, Bloom FE, Roth RH. Catecholamines II: CNS aspects. In: Cooper JR, Bloom FE, Roth RH, (eds). The Biochemical Basis of Neuropharmacology. New York: Oxford University Press; 1978: 161-195.
20. Satterfield JH, Schell AM, Nicholas TW, et al. Ontogeny of selective attention effects on event-related potentials in attention-deficit hyperactivity disorder and normal boys. Biological Psychiatry 1990; 28: 879-903.
21. Davies MG, Rowan MJ, MacMathuna P, et al. The auditory P300 event-related potential: an objective marker of the encephalopathy of chronic liver disease. Hepatology 1990; 12: 688-694.
22. Sangal RB, Sangal JM. Closed head injury patients with mild cognitive complaints without neurological or psychiatric findings have abnormal visual P300 latencies. Biological Psychiatry 1996; 39: 305-307.
23. Taylor MJ, Keenan NK. Event-related potentials to visual and language stimuli in normal and dyslexic children. Psychophysiology 1990; 27: 318-327.
24. Barkley RA. A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 1977; 18: 137-165.
25. Biederman J, Jellinek MS. Psychopharmacology in children. N Engl J Med 1984; 310: 968-972.
26. Biederman J. Adolescence, do we use the same treatments? Psychopharmacology Bulletin 1988; 24: 81-87.
27. Barkley RA, DuPaul GJ, McMurray MB. Attention Deficit Disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate. Pediatrics 1991; 87: 519-531.